Ainos (AIMD, Financial) has achieved a significant enhancement in its AI Nose platform, which now boasts approximately 85% accuracy in detecting excretion odors, up from its previous 80%. This advancement stems from data collected from 254 participants across Japan and Taiwan, which resulted in 2119 valid entries for analysis. This achievement underscores the potential of AI Nose as a viable solution for non-contact hygiene monitoring, especially in long-term care settings, positioning Ainos as a leader in the emerging SmellTech industry.
The AI Nose system functions by translating odors into Smell IDs through the use of MEMS gas sensors and proprietary AI models, leveraging over a decade of scent data from various healthcare and industrial applications. Its compact design allows for easy integration into portable devices and ambient or robotic platforms, making it highly adaptable.
Ainos is focusing on addressing the needs of an aging population by aligning its technology with government initiatives to digitize elderly care and alleviate institutional demands. The company targets impactful applications such as automated hygiene alerts, early incontinence detection, optimizing caregiver workflows, and preventing skin injuries and infections through scent-triggered interventions.
